Central challenges facing the national clinical research enterprise
- PMID: 12633190
- DOI: 10.1001/jama.289.10.1278
Central challenges facing the national clinical research enterprise
Abstract
Medical scientists and public health policy makers are increasingly concerned that the scientific discoveries of the past generation are failing to be translated efficiently into tangible human benefit. This concern has generated several initiatives, including the Clinical Research Roundtable at the Institute of Medicine, which first convened in June 2000. Representatives from a diverse group of stakeholders in the nation's clinical research enterprise have collaborated to address the issues it faces. The context of clinical research is increasingly encumbered by high costs, slow results, lack of funding, regulatory burdens, fragmented infrastructure, incompatible databases, and a shortage of qualified investigators and willing participants. These factors have contributed to 2 major obstacles, or translational blocks: impeding the translation of basic science discoveries into clinical studies and of clinical studies into medical practice and health decision making in systems of care. Considering data from across the entire health care system, it has become clear that these 2 translational blocks can be removed only by the collaborative efforts of multiple system stakeholders. The goal of this article is to articulate the 4 central challenges facing clinical research at present--public participation, information systems, workforce training, and funding; to make recommendations about how they might be addressed by particular stakeholders; and to invite a broader, participatory dialogue with a view to improving the overall performance of the US clinical research enterprise.
Comment in
-
Translating biomedical research to the bedside: a national crisis and a call to action.JAMA. 2003 Mar 12;289(10):1305-6. doi: 10.1001/jama.289.10.1305. JAMA. 2003. PMID: 12633194 No abstract available.
Similar articles
-
American Society of Clinical Oncology policy statement: oversight of clinical research.J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29. J Clin Oncol. 2003. PMID: 12721281
-
Meeting the challenges facing clinical research: solutions proposed by leaders of medical specialty and clinical research societies.Acad Med. 2006 Feb;81(2):107-12. doi: 10.1097/00001888-200602000-00002. Acad Med. 2006. PMID: 16436570 Review.
-
Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise.JAMA. 2004 Mar 3;291(9):1120-6. doi: 10.1001/jama.291.9.1120. JAMA. 2004. PMID: 14996782
-
Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.JAMA. 2003 Sep 24;290(12):1624-32. doi: 10.1001/jama.290.12.1624. JAMA. 2003. PMID: 14506122
-
National EMS Research Agenda.Prehosp Emerg Care. 2002 Jul-Sep;6(3 Suppl):S1-43. Prehosp Emerg Care. 2002. PMID: 12108581 Review.
Cited by
-
Research Integrated Network of Systems (RINS): a virtual data warehouse for the acceleration of translational research.J Am Med Inform Assoc. 2021 Jul 14;28(7):1440-1450. doi: 10.1093/jamia/ocab023. J Am Med Inform Assoc. 2021. PMID: 33729486 Free PMC article.
-
Characteristics of successful recruitment in prospective pediatric pharmacogenetic studies.Clin Ther. 2011 Dec;33(12):2072-81. doi: 10.1016/j.clinthera.2011.10.026. Epub 2011 Dec 2. Clin Ther. 2011. PMID: 22136977 Free PMC article.
-
The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology.J Cardiovasc Dev Dis. 2024 Feb 5;11(2):56. doi: 10.3390/jcdd11020056. J Cardiovasc Dev Dis. 2024. PMID: 38392270 Free PMC article. Review.
-
Toward a Modern Science of Obesity at Washington University: How We Do It and What is the Payoff?Cancer Prev Res (Phila). 2016 Jul;9(7):503-8. doi: 10.1158/1940-6207.CAPR-15-0060. Epub 2016 Apr 8. Cancer Prev Res (Phila). 2016. PMID: 27059763 Free PMC article.
-
Knowledge mobilization in healthcare organizations: a view from the resource-based view of the firm.Int J Health Policy Manag. 2015 Feb 20;4(3):127-30. doi: 10.15171/ijhpm.2015.35. eCollection 2015 Mar. Int J Health Policy Manag. 2015. PMID: 25774369 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous